Processa Pharmaceuticals, Inc. — Director's Dealing 2020

Oct 5, 2020

SEC Form 3/A — Form 3/A

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2020-10-02

Reporting Person: Yorke Justin W (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants (Right to Buy)	$17.164	2021-05-25	Common Stock (73657)		Indirect

Footnotes

F1: This amended Form 3 is being filed to add the grant date/exercise date of the warrants issued to the reporting person.